COMMUNIQUÉS West-GlobeNewswire

Olympia Pharmaceuticals Unveils Circulate, Expanding Its Single-Dose IV Nutritional Therapy Line
18/02/2026
New vascular health formula designed with blood flow and cellular energy in mind through a streamlined, ready-to-use delivery system ORLANDO, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals , a leader in [...]
As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense
18/02/2026
OSHA standardizes on Mesa’s DryCal Defender technology for field enforcement as industry faces generational knowledge gap in flow calibration LAKEWOOD, Colo., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. ( [...]
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
18/02/2026
MELBOURNE, Australia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel treatments for recurrent and metastatic cancer, [...]
24/7 Market News- It’s Not Synthetic, It’s Real. Kraig Labs Nears Spider Silk Breakthrough
18/02/2026
One Million Transgenic Silkworms Being Deployed as Production Targets 10 Metric Tons per Month DENVER, Feb. 18, 2026 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution [...]
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
18/02/2026
Conference Call Scheduled for Thursday, March 5, 2026 at 9:00 AM ET PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that [...]
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
18/02/2026
IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced the appointment of David E. I. Pyott, a distinguished leader in the global biopharmaceutical industry and [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
18/02/2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
GLP-1 Usage Increases 67% While Bariatric Surgeries Decline, but Long-Term Benefits Remain Unclear
18/02/2026
GREENWICH, Conn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- A new analysis by Cedar Gate Technologies , an IQVIA business (Cedar Gate), found a 13% decline in bariatric surgery volume over the past year, alongside a 67% [...]
Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
18/02/2026
Patent strengthens protection for novel PTSD drug and advances the Company’s international IP strategy SARASOTA, FL, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a [...]
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
18/02/2026
Preliminary blinded CR rate showed 67% improvement over historical cytarabine response Roughly 35% of the subjects treated to date represent ventoclax regimen failures First 45 subjects treated on track for Q1 2026 [...]
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
18/02/2026
Approval Marks Biomerica’s Strategic Entry into Southeast Asia’s Rapidly Growing Healthcare Market Simple, FDA-Cleared At-Home Test Detects an Early Warning Sign of Colorectal Cancer in Minutes IRVINE, Calif., Feb. 18, [...]
Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need
18/02/2026
Stenoparib is being evaluated in combination with temozolomide clinical benefit in relapsed Small Cell Lung Cancer Trial is fully funded by the U.S. Department of Veterans Affairs and is open for enrollment at 11 VA [...]
Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser
18/02/2026
Latest STRATA customer strengthens academic leadership in XTRAC excimer laser treatment for psoriasis, vitiligo, and atopic dermatitis HORSHAM, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (Nasdaq: [...]
Alembic Therapeutics LLC Announces the Launch of PIVYA® (pivmecillinam)
18/02/2026
Pivya ® (pivmecillinam) Tablets, 185mg Now Available by Prescription in the United States BEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics is pleased to announce the U.S. availability of Pivya [...]
Elicio Therapeutics Reports Inducement Grants
18/02/2026
BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of [...]
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
18/02/2026
BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer [...]
Tenvie Therapeutics Appoints Don O’Sullivan, Ph.D., MBA, as Chief Business Officer
18/02/2026
Seasoned biotechnology executive with more than 20 years of corporate and business development experience to lead strategic collaborations and business operations BRISBANE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- [...]
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference
18/02/2026
CLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body [...]
Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics
18/02/2026
Collaboration will harness UNP’s AI enhanced macrocycle platform to drug historically “undruggable” targets SANTA CRUZ, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing [...]

Pages